Regulatory Readiness for Paper Replacement in Global Pharmaceutical Electronic Labeling: Cross-Sectional Comparative Policy Analysis
Open Access
- 18 August 2026
- journal article
- research article
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e96787
Abstract
Background: Accurate and up-to-date medicinal product information is essential for the safe and effective use of medicines. Electronic labeling (e-labeling) has emerged as a potential alternative to paper-based package inserts by enabling timely updates, improving accessibility, and supporting integration with digital health systems. However, regulatory approaches to pharmaceutical e-labeling remain fragmented across jurisdictions. Objective: This study examined how e-labeling policies have developed across International Coalition of Medicines Regulatory Authorities (ICMRA) member jurisdictions and explored the conditions associated with policies that position e-labeling as a replacement for paper-based product information. Methods: We conducted a cross-sectional comparative policy analysis of publicly available national regulatory documents on pharmaceutical e-labeling issued between January 1, 2012, and May 31, 2026. The analysis focused on how regulatory intent, legal authority, implementation mechanisms, and replacement pathways were articulated in official policy documents across jurisdictions. A main corpus of official jurisdictional policy documents was supplemented by a triangulation corpus of international stakeholder documents. Hybrid thematic analysis and content analysis were used to identify and compare policy themes across jurisdictions. A 4-level e-labeling regulatory maturity framework was developed using 3 indicators: implementation status, level of authority, and expansion toward advanced considerations. Fuzzy-set qualitative comparative analysis (fsQCA) was then conducted across 19 jurisdictions to identify configurational patterns associated with paper-label replacement. Results: A total of 81 policy documents from 20 jurisdictions were included in the main analysis, and 27 documents were included in the triangulation corpus. Nine themes were identified across 3 domains: e-labeling scope and implementation strategy, operational infrastructure, and advanced considerations. Most policies addressed target product information, medicine categories, transition approaches, interface mechanisms, and responsible entities. In contrast, structured digital formats, interoperability, and personalized information were less consistently addressed. The maturity assessment showed substantial variation across jurisdictions. Brazil and the Netherlands were classified at the highest maturity level, reflecting implementation with a legal basis and expansion toward advanced functions. The fsQCA identified 1 conservative sufficient configuration associated with paper-label replacement: digital infrastructure readiness, high e-labeling policy maturity, and explicit responsibility of the marketing authorization holder. Conclusions: Pharmaceutical e-labeling has moved beyond early policy discussion in many ICMRA member jurisdictions, but regulatory maturity remains uneven. While most jurisdictions enable electronic access to product information, relatively few have established the legal and operational foundations to replace paper labeling. Paper-label replacement was associated with mature regulatory frameworks and clear operational responsibility. By combining a cross-jurisdictional regulatory maturity framework with fsQCA, this study provides a novel comparative approach that extends beyond previous descriptive studies by identifying the conditions associated with paper-label replacement. The proposed framework may offer a structured approach to assessing regulatory readiness and prioritizing the efforts required for effective legal development and implementation.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Harmonization of E-Labelling (Electronic Patient Information Leaflet) in Pharmaceuticals: A Global PerspectiveInternational Journal of Drug Regulatory Affairs, 2025
- Acceptance of Electronic Labeling for Medicinal Product Information Among Malaysian Hospital Patients: Cross-Sectional StudyJournal of Medical Internet Research, 2024
- Evaluation of the design and structure of electronic medication labels to improve patient health knowledge and safety: a systematic reviewSystematic Reviews, 2024
- Benefits and challenges of electronic package leaflet (ePL) - review of ePL pilots in hospital settings in EuropeEuropean Journal of Pharmaceutical Sciences, 2023
- Survey Result for E-labeling Initiatives in AsiaTherapeutic Innovation & Regulatory Science, 2022
- Smart Healthcare in the Age of AI: Recent Advances, Challenges, and Future ProspectsIEEE Access, 2021
- Fuzzy-set Qualitative Comparative Analysis (fsQCA): Guidelines for research practice in Information Systems and marketingInternational Journal of Information Management, 2021
- PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic ReviewsSystematic Reviews, 2021
- Internet of Things for In-Home Health Monitoring Systems: Current Advances, Challenges and Future DirectionsIEEE Journal on Selected Areas in Communications, 2021
- Standards for Reporting Qualitative ResearchAcademic Medicine, 2014